⌘K

Hervycta 150 + Injection

Images are for reference. Actual packaging may vary.

Vial of 1 injection • InjectionPrescription requiredSchedule H

Hervycta 150 + Injection

Name: Hervycta 150 + Injection
Brand: Dr Reddy's Laboratories Ltd
SKU: 8ac9f177-13d1-49d6-82e0-48976e0bf7c6

Trastuzumab (150mg)

Dr Reddy's Laboratories Ltd Hypertension

₹20300.00

Vial of 1 injection • Injection

A valid prescription is required for this medicine.

Delivery

Safe & Secure

Easy Returns

24/7 Support

SMARTER CARE

A little guidance.
A better choice.

Haven’t found an alternative? A health advisor can help you understand what to do next.

No matching alternative found

We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.

Talk to a health advisor

Why consult an advisor?

Compare all generic substitutes

Active composition

Trastuzumab 150 mg

How It Works

Trastuzumab binds to the HER2 receptor, inhibiting signaling pathways that promote cancer cell proliferation.

Medicine Strength

150 mg

Uses & Benefits

Medical applications

Hervycta 150 + Injection contains Trastuzumab 150 mg, a recombinant humanized monoclonal antibody targeting the HER2 receptor, which is overexpressed in certain types of breast and gastric cancers. Hervycta 150 + Injection is indicated for the treatment of HER2-positive metastatic breast cancer, early-stage breast cancer as adjuvant therapy, and HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma.

Read full descriptionShow less

By binding specifically to the extracellular domain of the HER2 receptor, Trastuzumab inhibits tumor cell proliferation and mediates antibody-dependent cellular cytotoxicity. The administration of Hervycta 150 + Injection requires intravenous infusion, typically initiated with a loading dose followed by maintenance doses at regular intervals as per oncological protocols. Prior to initiation, patients should be evaluated for cardiac function due to the potential risk of cardiotoxicity associated with Trastuzumab therapy.

Monitoring during treatment includes periodic assessment of left ventricular ejection fraction and vigilance for infusion-related reactions. Hervycta 150 + Injection should be used under strict medical supervision, with dosage adjustments based on clinical response and tolerability. It is contraindicated in patients with known hypersensitivity to Trastuzumab or any of its excipients.

This product represents a targeted therapeutic option aimed at improving clinical outcomes in HER2-positive malignancies.

Dosage & How to Use

Monoclonal antibody (mAb)

Safety Advice

Important precautions

Side effects

Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.

Safety Advice

Alcohol

Hervycta 150 + Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

High Risk

Pregnancy

Hervycta 150 + Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Medical Advice

Driving

Hervycta 150 + Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Hervycta 150 + Injection may not be needed in these patients. Please consult your doctor.

Exercise Caution

Breastfeeding

It is not known whether Hervycta 150 + Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Consult Doctor

Kidney

There is limited information available on the use of Hervycta 150 + Injection in patients with liver disease. Please consult your doctor.

Regular Checkup

Customer Reviews

0 reviews for Hervycta 150 + Injection

Hervycta 150 + Injection